Kenvue Inc. (KVUE) PB Ratio: 3.34
Is Kenvue Inc.’s P/B ratio high or low?
Kenvue Inc.'s P/B ratio of 3.34 is in line with its 3-year average of 3.64, around the middle of its 3-year range (2.53–4.78).
6.32% above its 12-month average of 3.14.
KVUE PB Ratio Chart
KVUE Average PB Ratio Chart
KVUE Current vs Average PB Ratio Chart
KVUE PB Ratio Metrics
PB RATIO
3.34
PB RATIO AVG TTM
3.14
PB RATIO AVG 3Y
3.64
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.32%
CURRENT VS 3Y AVG
-8.24%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
KVUE Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kenvue Inc. (KVUE) | $35.35B | 3.34 | 3.14 | 3.64 | N/A |
| Kimberly-Clark Corp (KMB)vs › | $35.43B | 19.80 | 27.17 | 43.61 | 59.47 |
| The Kroger Co. (KR)vs › | $36.06B | 5.55 | 5.81 | 4.30 | 4.02 |
| The Hershey Company (HSY)vs › | $36.36B | 7.74 | 8.42 | 9.17 | 11.82 |
| Archer-Daniels-Midland Company (ADM)vs › | $36.55B | 1.61 | 1.39 | 1.36 | 1.57 |
| Sysco Corporation (SYY)vs › | $38.54B | 16.88 | 18.27 | 18.22 | 22.80 |
| The Estée Lauder Companies Inc. (EL)vs › | $30.12B | 7.62 | 8.38 | 7.79 | 11.41 |
| Kellanova (K)vs › | $29.03B | 6.95 | 7.28 | 6.35 | 6.24 |
| Keurig Dr Pepper Inc. (KDP)vs › | $42.72B | 1.70 | 1.57 | 1.74 | 1.87 |
| The Kraft Heinz Company (KHC)vs › | $26.64B | 0.64 | 0.69 | 0.78 | 0.85 |
P/B vs. its own history
At 3.34, P/B is in its normal range, sitting higher than 41% of its 3-year history.
3-year low
2.53
median
3.51
3-year high
4.78
Book Value Analysis
P/B Ratio
3.34
Market Price / Book Value per Share
Kenvue Inc. PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Kenvue Inc. PB Ratio FAQ
- What is the P/B ratio for Kenvue Inc. (KVUE)?
- The P/B ratio for KVUE stock is 3.34.
- Is Kenvue Inc.'s P/B ratio high or low?
- Kenvue Inc.'s P/B ratio of 3.34 is in line with its 3-year average of 3.64, around the middle of its 3-year range (2.53–4.78).
- What is the TTM average P/B ratio for Kenvue Inc. (KVUE)?
- The TTM average P/B ratio for KVUE stock is 3.14.
- What is the 3Y average P/B ratio for Kenvue Inc. (KVUE)?
- The 3Y average P/B ratio for KVUE stock is 3.64.
Kenvue Inc. PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-23 | 3.34 |
| 2026-06-22 | 3.24 |
| 2026-06-18 | 3.28 |
| 2026-06-17 | 3.26 |
| 2026-06-16 | 3.34 |
| 2026-06-15 | 3.31 |
| 2026-06-12 | 3.29 |
| 2026-06-11 | 3.27 |
| 2026-06-10 | 3.27 |
| 2026-06-09 | 3.25 |
| 2026-06-08 | 3.18 |
| 2026-06-05 | 3.21 |
| 2026-06-04 | 3.06 |
| 2026-06-03 | 3.05 |
| 2026-06-02 | 3.14 |
| 2026-06-01 | 3.14 |
| 2026-05-29 | 3.13 |
| 2026-05-28 | 3.20 |
| 2026-05-27 | 3.21 |
| 2026-05-26 | 3.17 |
| 2026-05-22 | 3.18 |
| 2026-05-21 | 3.16 |
| 2026-05-20 | 3.14 |
| 2026-05-19 | 3.11 |
| 2026-05-18 | 3.11 |
| 2026-05-15 | 3.10 |
| 2026-05-14 | 3.11 |
| 2026-05-13 | 3.11 |
| 2026-05-12 | 3.17 |
| 2026-05-11 | 3.11 |
| 2026-05-08 | 3.19 |
| 2026-05-07 | 3.21 |
| 2026-05-06 | 3.15 |
| 2026-05-05 | 3.10 |
| 2026-05-04 | 3.06 |
| 2026-05-01 | 3.11 |
| 2026-04-30 | 3.13 |
| 2026-04-29 | 3.07 |
| 2026-04-28 | 3.13 |
| 2026-04-27 | 3.13 |
| 2026-04-24 | 3.12 |
| 2026-04-23 | 3.12 |
| 2026-04-22 | 3.09 |
| 2026-04-21 | 3.09 |
| 2026-04-20 | 3.14 |
| 2026-04-17 | 3.14 |
| 2026-04-16 | 3.11 |
| 2026-04-15 | 3.09 |
| 2026-04-14 | 3.10 |
| 2026-04-13 | 3.08 |
| 2026-04-10 | 3.09 |
| 2026-04-09 | 3.11 |
| 2026-04-08 | 3.09 |
| 2026-04-07 | 2.98 |
| 2026-04-06 | 3.09 |
| 2026-04-02 | 3.06 |
| 2026-04-01 | 3.10 |
| 2026-03-31 | 3.07 |
| 2026-03-30 | 3.07 |
| 2026-03-27 | 3.12 |
| 2026-03-26 | 3.13 |
| 2026-03-25 | 3.15 |
| 2026-03-24 | 3.13 |
| 2026-03-23 | 3.14 |
| 2026-03-20 | 3.10 |
| 2026-03-19 | 3.11 |
| 2026-03-18 | 3.12 |
| 2026-03-17 | 3.17 |
| 2026-03-16 | 3.16 |
| 2026-03-13 | 3.12 |
| 2026-03-12 | 3.10 |
| 2026-03-11 | 3.15 |
| 2026-03-10 | 3.20 |
| 2026-03-09 | 3.24 |
| 2026-03-06 | 3.28 |
| 2026-03-05 | 3.25 |
| 2026-03-04 | 3.24 |
| 2026-03-03 | 3.24 |
| 2026-03-02 | 3.37 |
| 2026-02-27 | 3.41 |
| 2026-02-26 | 3.39 |
| 2026-02-25 | 3.35 |
| 2026-02-24 | 3.39 |
| 2026-02-23 | 3.38 |
| 2026-02-20 | 3.34 |
| 2026-02-19 | 3.37 |
| 2026-02-18 | 3.41 |
| 2026-02-17 | 3.33 |
| 2026-02-13 | 3.38 |
| 2026-02-12 | 3.35 |
| 2026-02-11 | 3.35 |
| 2026-02-10 | 3.31 |
| 2026-02-09 | 3.29 |
| 2026-02-06 | 3.28 |
| 2026-02-05 | 3.27 |
| 2026-02-04 | 3.26 |
| 2026-02-03 | 3.18 |
| 2026-02-02 | 3.14 |
| 2026-01-30 | 3.15 |
| 2026-01-29 | 3.11 |
| 2026-01-28 | 3.14 |
| 2026-01-27 | 3.16 |
| 2026-01-26 | 3.19 |
| 2026-01-23 | 3.22 |
| 2026-01-22 | 3.21 |
| 2026-01-21 | 3.14 |
| 2026-01-20 | 3.18 |
| 2026-01-16 | 3.11 |
| 2026-01-15 | 3.12 |
| 2026-01-14 | 3.10 |
| 2026-01-13 | 3.08 |
| 2026-01-12 | 3.07 |
| 2026-01-09 | 3.04 |
| 2026-01-08 | 3.07 |
| 2026-01-07 | 3.03 |
| 2026-01-06 | 3.03 |
| 2026-01-05 | 3.04 |
| 2026-01-02 | 3.13 |
| 2025-12-31 | 3.12 |
| 2025-12-30 | 3.14 |
| 2025-12-29 | 3.11 |
| 2025-12-26 | 3.11 |
| 2025-12-24 | 3.11 |
| 2025-12-23 | 3.08 |
| 2025-12-22 | 3.08 |
| 2025-12-19 | 3.08 |
| 2025-12-18 | 3.09 |
| 2025-12-17 | 3.12 |
| 2025-12-16 | 3.12 |
| 2025-12-15 | 3.11 |
| 2025-12-12 | 3.13 |
| 2025-12-11 | 3.13 |
| 2025-12-10 | 3.13 |
| 2025-12-09 | 3.08 |
| 2025-12-08 | 3.03 |
| 2025-12-05 | 3.06 |
| 2025-12-04 | 3.07 |
| 2025-12-03 | 3.07 |
| 2025-12-02 | 3.05 |
| 2025-12-01 | 3.11 |
| 2025-11-28 | 3.14 |
| 2025-11-26 | 3.11 |
| 2025-11-25 | 3.08 |
| 2025-11-24 | 3.03 |
| 2025-11-21 | 3.01 |
| 2025-11-20 | 2.92 |
| 2025-11-19 | 2.90 |
| 2025-11-18 | 2.93 |
| 2025-11-17 | 2.94 |
| 2025-11-14 | 3.01 |
| 2025-11-13 | 3.03 |
| 2025-11-12 | 3.01 |
| 2025-11-11 | 3.02 |
| 2025-11-10 | 3.03 |
| 2025-11-07 | 3.05 |
| 2025-11-06 | 2.98 |
| 2025-11-05 | 2.93 |
| 2025-11-04 | 2.89 |
| 2025-11-03 | 2.92 |
| 2025-10-31 | 2.58 |
| 2025-10-30 | 2.56 |
| 2025-10-29 | 2.57 |
| 2025-10-28 | 2.61 |
| 2025-10-27 | 2.71 |
| 2025-10-24 | 2.69 |
| 2025-10-23 | 2.71 |
| 2025-10-22 | 2.73 |
| 2025-10-21 | 2.68 |
| 2025-10-20 | 2.69 |
| 2025-10-17 | 2.75 |
| 2025-10-16 | 2.53 |
| 2025-10-15 | 2.92 |
| 2025-10-14 | 2.90 |
| 2025-10-13 | 2.91 |
| 2025-10-10 | 2.99 |
| 2025-10-09 | 3.02 |
| 2025-10-08 | 2.89 |
| 2025-10-07 | 2.91 |
| 2025-10-06 | 2.82 |
| 2025-10-03 | 2.84 |
| 2025-10-02 | 2.82 |
| 2025-10-01 | 2.85 |
| 2025-09-30 | 2.91 |
| 2025-09-29 | 2.93 |
| 2025-09-26 | 2.95 |
| 2025-09-25 | 2.90 |
| 2025-09-24 | 3.03 |
| 2025-09-23 | 3.10 |
| 2025-09-22 | 3.05 |
| 2025-09-19 | 3.29 |
| 2025-09-18 | 3.25 |
| 2025-09-17 | 3.29 |
| 2025-09-16 | 3.26 |
| 2025-09-15 | 3.28 |
| 2025-09-12 | 3.41 |
| 2025-09-11 | 3.39 |
| 2025-09-10 | 3.32 |
| 2025-09-09 | 3.39 |
| 2025-09-08 | 3.31 |
| 2025-09-05 | 3.34 |
| 2025-09-04 | 3.69 |
| 2025-09-03 | 3.67 |
| 2025-09-02 | 3.73 |
| 2025-08-29 | 3.72 |
| 2025-08-28 | 3.69 |
| 2025-08-27 | 3.73 |
| 2025-08-26 | 3.73 |
| 2025-08-25 | 3.81 |
| 2025-08-22 | 3.88 |
| 2025-08-21 | 3.85 |
| 2025-08-20 | 3.88 |
| 2025-08-19 | 3.86 |
| 2025-08-18 | 3.79 |
| 2025-08-15 | 3.81 |
| 2025-08-14 | 3.78 |
| 2025-08-13 | 3.90 |
| 2025-08-12 | 3.93 |
| 2025-08-11 | 3.81 |
| 2025-08-08 | 3.83 |
| 2025-08-07 | 3.91 |
| 2025-08-06 | 4.11 |
| 2025-08-05 | 4.14 |
| 2025-08-04 | 4.25 |
| 2025-08-01 | 4.13 |
| 2025-07-31 | 4.11 |
| 2025-07-30 | 4.15 |
| 2025-07-29 | 4.25 |
| 2025-07-28 | 4.28 |
| 2025-07-25 | 4.37 |
| 2025-07-24 | 4.31 |
| 2025-07-23 | 4.32 |
| 2025-07-22 | 4.34 |
| 2025-07-21 | 4.24 |
| 2025-07-18 | 4.21 |
| 2025-07-17 | 4.18 |
| 2025-07-16 | 4.18 |
| 2025-07-15 | 4.10 |
| 2025-07-14 | 4.18 |
| 2025-07-11 | 4.09 |
| 2025-07-10 | 4.01 |
| 2025-07-09 | 3.98 |
| 2025-07-08 | 3.96 |
| 2025-07-07 | 4.00 |
| 2025-07-03 | 4.03 |
| 2025-07-02 | 4.00 |
| 2025-07-01 | 4.02 |
| 2025-06-30 | 4.01 |
| 2025-06-27 | 4.00 |
| 2025-06-26 | 4.04 |
| 2025-06-25 | 4.05 |
| 2025-06-24 | 4.06 |
| 2025-06-23 | 4.09 |
| 2025-06-20 | 4.10 |
| 2025-06-18 | 4.09 |
| 2025-06-17 | 4.11 |
| 2025-06-16 | 4.15 |
| 2025-06-13 | 4.11 |
| 2025-06-12 | 4.22 |
| 2025-06-11 | 4.18 |
| 2025-06-10 | 4.12 |
Showing the most recent 260 of 747 data points. The chart above shows the full history.
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry